Publication

Europe’s Preventable RSV Winter
New ECDC modelling suggests that protecting newborns against RSV could prevent a substantial share of infant hospitalisations during the first months of life. Under a scenario reaching 90% of newborns with long-acting monoclonal antibodies, 61% of RSV hospitalisations in the first two months could be prevented. Europe has the preventive tools. The challenge is making…

Cardiometabolic care tracks glucose and blood pressure

ALS Immune Signals Depend on Where You Look

Europe Has Plans. Implementation Is Lagging

Cardiac amyloidosis is no longer the whole story of protein misfolding

Brown fat is looking less like a metabolic curiosity and more like a drug target

ESCAT v2 Makes Resistance Clinically Actionable

A Second Step for Alzheimer’s Blood Tests

A Genetic Clue to Spinal Leukodystrophy

Endometrial Cancer Gets a Strong ADC Win
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
